
Opinion|Videos|September 27, 2024
Introduction: Risk Factors and Characteristics Defining SCLC
Key Takeaways
- SCLC is more aggressive than NSCLC, characterized by rapid growth and early metastasis, leading to poorer outcomes.
- Limited-stage SCLC is confined to one hemithorax, while extensive-stage involves distant metastasis, affecting prognosis significantly.
Panelists discuss how small cell lung cancer (SCLC) differs from non–small cell lung cancer in terms of staging, epidemiology, risk factors, prevention strategies, and prognosis, while also exploring the distinctions between limited-stage and extensive-stage SCLC and considering potential improvements in staging practices.
Advertisement
Episodes in this series

Now Playing
- How is small cell lung cancer (SCLC) different than other types of lung cancer, specifically non–small cell lung cancer (NSCLC)? What are the differences between limited-stage and extensive-stage SCLC?
- What is the epidemiology associated with SCLC, and what are the prognoses associated with limited-stage and extensive-stage SCLC?
- What are the main risk factors associated with SCLC, how can this disease be prevented, and what are the best strategies for promoting prevention to patients?
- How do you stage SCLC in your practice in terms of extensive and limited-stage disease? How can staging be improved in the future?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
A "One-Two Punch" to Innovation? The Most Favored Nation Order and Broader US Drug Pricing Reform
2
Telemedicine Boosts Quality of Life, Inhaler Technique for Severe COPD
3
Bispecific Antibodies in Multiple Myeloma Are Moving From Clinical Trials to Community Practice
4
White House to Announce Second Drug Pricing Deal as AstraZeneca Joins TrumpRx
5